Complementary/Alternative Medicine: This monograph describes a natural or herbal product that is not subject to FDA guidelines for medicines. Patients and clinicians are advised to read package labels carefully to ensure safe and efficacious use.
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
- Ma huang
- Ephedra sinesis
central nervous system stimulants
There's more to see -- the rest of this topic is available only to subscribers.
Vallerand, April Hazard., et al. "Ephedra." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109119/1/ephedra.
Vallerand AHA, Sanoski CAC, Quiring CC. Ephedra. Davis's Drug Guide. F.A. Davis Company; 2023. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109119/1/ephedra. Accessed June 7, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Ephedra. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109119/1/ephedra
Vallerand AHA, Sanoski CAC, Quiring CC. Ephedra [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 June 07]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109119/1/ephedra.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - ephedra ID - 109119 A1 - Sanoski,Cynthia A, AU - Vallerand,April Hazard, AU - Quiring,Courtney, BT - Davis's Drug Guide UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109119/1/ephedra PB - F.A. Davis Company ET - 18 DB - Nursing Central DP - Unbound Medicine ER -